Largest biotech by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Gilead Sciences leads the 24 biotech ranked by net assets, at THB 770.8B, ahead of BioNTech (THB 724.1B) and Biogen (THB 619.8B). Figures as of 18 Nov 2026, 16:15 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- Gilead SciencesTHB 770.8B
- Median
- THB 68.4B
- Combined market value
- THB 28.49T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Gilead SciencesGILD · Health Care | THB 770.8B | THB 7.1T | THB 5,722.61 | 1.00% down | 33% up | ||
| 2 | BioNTechBNTX · Health Care | THB 724.1B | THB 707.2B | THB 2,852.48 | 0.99% down | 16% down | ||
| 3 | BiogenBIIB · Health Care | THB 619.8B | THB 1.25T | THB 8,465.94 | 0.57% down | 49% up | ||
| 4 | AmgenAMGN · Health Care | THB 293.9B | THB 8.21T | THB 15,177.01 | 2.38% down | 34% up | ||
| 5 | ModernaMRNA · Health Care | THB 293.7B | THB 2.76T | THB 6,817.80 | 2.89% down | 755% up | ||
| 6 | argenxARGX · Health Care | THB 248.6B | THB 2.02T | THB 32,115.51 | 0.16% down | 4% up | ||
| 7 | QiagenQGEN · Health Care | THB 128.3B | THB 347.5B | THB 1,682.90 | 0.36% down | 12% up | ||
| 8 | Neurocrine BiosciencesNBIX · Health Care | THB 110.4B | THB 557.9B | THB 5,511.78 | 2.15% down | 20% up | ||
| 9 | VaxcytePCVX · Health Care | THB 91.2B | THB 316.6B | THB 1,999.82 | 0.83% down | 22% up | ||
| 10 | ExelixisEXEL · Health Care | THB 73.4B | THB 570.6B | THB 2,338.48 | 0.55% up | 63% up | ||
| 11 | Bio-TechneTECH · Health Care | THB 71.6B | THB 387.9B | THB 2,469.01 | 0.13% up | 26% up | ||
| 12 | RepligenRGEN · Health Care | THB 71.5B | THB 369.9B | THB 5,786.78 | 5.10% up | 5% up | ||
| 13 | CRISPR TherapeuticsCRSP · Health Care | THB 65.2B | THB 135.9B | THB 1,401.46 | 2.81% up | 21% down | ||
| 14 | Revolution MedicinesRVMD · Health Care | THB 55.4B | THB 1.17T | THB 5,428.10 | 1.72% down | 131% up | ||
| 15 | Kymera TherapeuticsKYMR · Health Care | THB 53.6B | THB 349.2B | THB 4,090.30 | 0.86% down | 87% up | ||
| 16 | Krystal BiotechKRYS · Health Care | THB 41.4B | THB 310.4B | THB 10,475.78 | 3.35% up | 46% up | ||
| 17 | ImmunovantIMVT · Health Care | THB 28.9B | THB 236.3B | THB 1,141.74 | 1.26% up | 43% up | ||
| 18 | CG OncologyCGON · Health Care | THB 25.6B | THB 241.2B | THB 2,700.72 | 0.77% up | 85% up | ||
| 19 | Twist BioscienceTWST · Health Care | THB 16.1B | THB 266.2B | THB 3,904.25 | 2.68% up | 340% up | ||
| 20 | Scholar Rock HoldingSRRK · Health Care | THB 8.3B | THB 196B | THB 1,606.85 | 4.99% up | 14% up | ||
| 21 | Adaptive BiotechnologiesADPT · Health Care | THB 7.4B | THB 154.5B | THB 954.33 | 1.33% down | 88% up | ||
| 22 | Kodiak SciencesKOD · Health Care | THB 5.3B | THB 213.4B | THB 3,262.60 | 0.72% down | 396% up | ||
| 23 | Halozyme TherapeuticsHALO · Health Care | THB 1.7B | THB 374.9B | THB 3,287.89 | 0.91% up | 37% up | ||
| 24 | ImmunityBioIBRX · Health Care | -THB 17B | THB 238.7B | THB 224.41 | 5.59% up | 193% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 33.9500 THB).
Questions and answers
Which biotech rank first by net assets?
Gilead Sciences (THB 770.8B), BioNTech (THB 724.1B) and Biogen (THB 619.8B) are the top three of the 24 biotech ranked by net assets as of 18 Nov 2026, 16:15 UTC.
How many biotech are in this ranking?
24 are ranked by net assets.
What are these biotech worth together?
The 24 biotech ranked by net assets have a combined market value of THB 28.49T as of 18 Nov 2026, 16:15 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.